Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. by Benoit J Arsenault, Philip Barter, David A DeMicco, Weihang Bao, Gregory M Preston, John C LaRosa, Scott M Grundy, Prakash Deedwania, Heiner Greten, Nanette K Wenger, James Shepherd, David D Waters, John J P Kastelein, Treating to New Targets (TNT) Investigators

Get full text

Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD by Jonathan Arnold, Deeksha Acharya, Hetal Boricha, Himal Chapagain, Aleesha Kainat, Allison Bradley, Jong-Hyeon Jeong, Kevin A. Townsend, Mohammad B. Ateya, David A. DeMicco, YousefAlish, Michael J. Becich, Cynthia H. Chuang, Soledad A. Fernandez, Daniel E. Ford, Wenke Hwang, H. Lester Kirchner, Richard Morgan, Anuradha Paranjape, Neena A. Thomas, David A. Williams, RozelleHegeman-Dingle, Euan McLeod, Phillip A. Saccone, Kathleen M. McTigue

Get full text